167 related articles for article (PubMed ID: 28368506)
1. Multimodality Treatment of Skull Base Chondrosarcomas: The Role of Histology Specific Treatment Protocols.
Raza SM; Gidley PW; Meis JM; Grosshans DR; Bell D; DeMonte F
Neurosurgery; 2017 Sep; 81(3):520-530. PubMed ID: 28368506
[TBL] [Abstract][Full Text] [Related]
2. Proposed Treatment Paradigm for Intracranial Chondrosarcomas Based on Multidisciplinary Coordination.
Li D; Weng JC; Zhang GJ; Hao SY; Tang J; Zhang LW; Wang L; Wu Z; Jia W; Zhang JT
World Neurosurg; 2018 Jan; 109():e517-e530. PubMed ID: 29033377
[TBL] [Abstract][Full Text] [Related]
3. Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management.
Raza SM; Ramakrishna R; Weber RS; Kupferman ME; Gidley PW; Hanna EY; DeMonte F
J Neurosurg; 2015 Sep; 123(3):781-8. PubMed ID: 25909577
[TBL] [Abstract][Full Text] [Related]
4. Skull base chondrosarcoma: evidence-based treatment paradigms.
Bloch O; Parsa AT
Neurosurg Clin N Am; 2013 Jan; 24(1):89-96. PubMed ID: 23174360
[TBL] [Abstract][Full Text] [Related]
5. Skull base chondrosarcoma radiosurgery: report of the North American Gamma Knife Consortium.
Kano H; Sheehan J; Sneed PK; McBride HL; Young B; Duma C; Mathieu D; Seymour Z; McDermott MW; Kondziolka D; Iyer A; Lunsford LD
J Neurosurg; 2015 Nov; 123(5):1268-75. PubMed ID: 26115468
[TBL] [Abstract][Full Text] [Related]
6. Effect comparisons among treatment measures on progression-free survival in patients with skull base chordomas: a retrospective study of 234 post-surgical cases.
Wang L; Tian K; Ma J; Wang K; Jia G; Wu Z; Zhang L; Zhang J
Acta Neurochir (Wien); 2017 Oct; 159(10):1803-1813. PubMed ID: 28699066
[TBL] [Abstract][Full Text] [Related]
7. Site-Specific Considerations in the Surgical Management of Skull Base Chondrosarcomas.
Raza SM; Gidley PW; Kupferman ME; Hanna EY; Su SY; DeMonte F
Oper Neurosurg (Hagerstown); 2018 Jun; 14(6):611-619. PubMed ID: 28962038
[TBL] [Abstract][Full Text] [Related]
8. Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes.
Dickey ID; Rose PS; Fuchs B; Wold LE; Okuno SH; Sim FH; Scully SP
J Bone Joint Surg Am; 2004 Nov; 86(11):2412-8. PubMed ID: 15523011
[TBL] [Abstract][Full Text] [Related]
9. [Dedifferentiated chondrosarcoma. A study of 13 clinical cases and review of the literature].
Anract P; Tomeno B; Forest M
Rev Chir Orthop Reparatrice Appar Mot; 1994; 80(8):669-80. PubMed ID: 7638395
[TBL] [Abstract][Full Text] [Related]
10. Determinants of Survival in Skull Base Chondrosarcoma: A National Cancer Database Study.
Merna C; Lehrich BM; Kshirsagar RS; Eide JG; Diaz-Aguilar LD; Goshtasbi K; Yasaka TM; Sahyouni R; Palmer JN; Adappa ND; Hsu FPK; Kuan EC
World Neurosurg; 2022 Feb; 158():e766-e777. PubMed ID: 34808412
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and patterns of care in adult skull base chondrosarcomas from the SEER database.
Jones PS; Aghi MK; Muzikansky A; Shih HA; Barker FG; Curry WT
J Clin Neurosci; 2014 Sep; 21(9):1497-502. PubMed ID: 24792724
[TBL] [Abstract][Full Text] [Related]
12. Patient, Disease, and Treatment-Related Factors Affecting Progression-Free and Disease-Specific Survival in Recurrent Chondrosarcomas of the Skull Base.
Snyder R; Gadot R; Gidley PW; Nader ME; Hanna EY; Su SY; DeMonte F; Raza SM
Oper Neurosurg (Hagerstown); 2023 Jan; 24(1):33-43. PubMed ID: 36519877
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
[TBL] [Abstract][Full Text] [Related]
14. Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma.
van Maldegem A; Conley AP; Rutkowski P; Patel SR; Lugowska I; Desar IME; Bovée JVMG; Gelderblom H
Oncologist; 2019 Jan; 24(1):110-116. PubMed ID: 30082492
[TBL] [Abstract][Full Text] [Related]
15. Adenoid cystic carcinoma of the skull base: results with an aggressive multidisciplinary approach.
Ramakrishna R; Raza SM; Kupferman M; Hanna E; DeMonte F
J Neurosurg; 2016 Jan; 124(1):115-21. PubMed ID: 26252456
[TBL] [Abstract][Full Text] [Related]
16. Falcine and parasagittal chondrosarcomas.
Safaee M; Clark AJ; Tihan T; Parsa AT; Bloch O
J Clin Neurosci; 2013 Sep; 20(9):1232-6. PubMed ID: 23759737
[TBL] [Abstract][Full Text] [Related]
17. Advanced chondrosarcomas: role of chemotherapy and survival.
Italiano A; Mir O; Cioffi A; Palmerini E; Piperno-Neumann S; Perrin C; Chaigneau L; Penel N; Duffaud F; Kurtz JE; Collard O; Bertucci F; Bompas E; Le Cesne A; Maki RG; Ray Coquard I; Blay JY
Ann Oncol; 2013 Nov; 24(11):2916-22. PubMed ID: 24099780
[TBL] [Abstract][Full Text] [Related]
18. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.
Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T
J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572
[TBL] [Abstract][Full Text] [Related]
19. Management of Recurrent or Progressing Skull Base Chondrosarcomas: Predictors of Long-Term Outcomes.
Breshears JD; DeMonte F; Habib A; Gidley PW; Raza SM
J Neurol Surg B Skull Base; 2021 Jul; 82(Suppl 3):e155-e165. PubMed ID: 34306931
[No Abstract] [Full Text] [Related]
20. Combination of microsurgery and Gamma Knife surgery for the treatment of intracranial chondrosarcomas.
Förander P; Rähn T; Kihlström L; Ulfarsson E; Mathiesen T
J Neurosurg; 2006 Dec; 105 Suppl():18-25. PubMed ID: 18503325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
